Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity. 1995

T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor 48109, USA.

It has been proposed that fluoropyrimidine-mediated cytotoxicity and radiosensitization are closely correlated. We have shown that HT29 human colon cancer cells transfected with the E. coli dUTPase gene are resistant to 5-fluorodeoxyuridine (FdUrd)-mediated cytotoxicity, presumably through more effective elimination of dUTP. We used these cells to assess the association between radiosensitization and cytotoxicity produced by FdUrd. The radiation sensitivities of the clones expressing elevated dUTPase activity (dutE clones) were similar to those of untransfected HT29 cells or HT29 cells which had been transfected with only the expression vector for the E. coli gene (con clones). We found that FdUrd produced similar increases in radiation sensitivity regardless of dUTPase activity. Levels of dUTPase in the dutE clones remained elevated during the entire period of FdUrd exposure, demonstrating that the lack of difference between dutE and Con clones was not a reflection of down-regulation of dUTPase activity by FdUrd. Flow cytometry showed that all clones progressed past the G1/S-phase boundary and into early S phase during FdUrd treatment. These data suggest that the mechanisms of FdUrd-mediated cytotoxicity and radiosensitization are not closely linked. These findings, combined with our previous investigations, are consistent with the hypothesis that radiosensitization occurs in cells which progress past the G1/S-phase boundary in the presence of FdUrd.

UI MeSH Term Description Entries
D011755 Pyrophosphatases A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-. Pyrophosphatase
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
March 2010, International journal of radiation oncology, biology, physics,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
September 2008, Molecular pharmacology,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
February 1978, Journal of immunology (Baltimore, Md. : 1950),
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
November 2007, International journal of radiation oncology, biology, physics,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
November 1994, International journal of radiation oncology, biology, physics,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
January 1996, Cancer chemotherapy and pharmacology,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
January 2000, Cancer chemotherapy and pharmacology,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
January 1991, Journal of ocular pharmacology,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
January 1965, Antimicrobial agents and chemotherapy,
T S Lawrence, and M A Davis, and E Y Chang, and C E Canman, and J Maybaum, and E H Radany
November 1963, International journal of radiation biology and related studies in physics, chemistry, and medicine,
Copied contents to your clipboard!